BioWorld Covergage LexaGene
LexaGene covered in BioWorld on the MiQLab’s ability to detect new variants of pathogens at point-of-care. Read more.
Rapid POC Diagnostics in Vet Medicine
Dr. Sam Stewart, DVM from Ethos, describes the benefits of rapid POC diagnostics in veterinary medicine. Ethos will implement LexaGene‘s MiQLab to help deliver innovative evidence-based patient care. The article is from fall IVC Journal vol. 10 issue 4. Read now.
BioSpace Coverage on LexaGene EUA Studies
Read BioSpace’s recent coverage of LexaGene’s plans to submit for FDA Emergency Use Authorization, and how the MiQLab™ system is ideally suited to test for COVID-19 variants at point-of-care. More.
Outbreak News Today coverage of EUA plans
LexaGene was recently covered by Outbreak News Today on the news that LexaGene will begin in-house testing for variants of COVID-19. Read the story here.
LexaGene featured by Medical Technology
LexaGene’s new automated testing platform: Massachusetts-based LexaGene is preparing to launch MiQLab, the company’s flagship product, which provides automated pathogen testing in one platform.
Article on Penn Vet and MiQLab
American Animal Hospital Association (AAHA)’s NEWStat publication reviews LexaGene’s MiQLab system in a recent feature. Dr. Shelley Rankin of Penn Vet discusses the recent placement of a MiQLab under LexaGene’s Early Access Program.
COVID Q&A with Infection Control Today
Dr. Jack Regan, LexaGene’s CEO gives his perspective on fighting COVID-19 with better diagnostics and automated PCR testing.
LexaGene mentioned in Future Lab
LexaGene mentioned in Trends in COVID-19 Testing: Diagnostics and Serological, on Future Lab by Biocompare
Insights: Why Tests Fail
LexaGene CEO Dr. Jack Regan featured in Science News email update 24 April 2020. Here is an excerpt from the newsletter featuring Dr. Regan’s insights: Q&A: When the tests fail To find out why fast diagnostic tests for COVID-19 sometimes fail, Science News talked to Jack Regan, a virologist who founded LexaGene, a company based in…
LexaGene in Forbes: Positioned to fight coronavirus pandemic
Forbes profile on LexaGene’s technology: ‘It’s hard to imagine a startup better positioned to respond to the coronavirus pandemic than Beverly, Massachusetts-based LexaGene.’
Dr. Regan quoted in Boston Herald
Dr. Jack Regan, CEO and Founder of LexaGene quoted in Boston Herald article on the potential resurgence of COVID-19 in the fall.
LexaGene featured in Clinical Lab Products
LexaGene featured in Clinical Lab Products: “LexaGene responds to demand for better diagnostics for COVID-19.”